Cargando...
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...
Gardado en:
| Publicado en: | Mult Scler |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405807/ https://ncbi.nlm.nih.gov/pubmed/28206828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517690823 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|